Sex differences in blood pressure response to antihypertensive therapy in Chinese patients with hypertension

Annals of Pharmacotherapy

Volumn 42, Issue 12, 2008, Pages 1772-1781

  Fan, XiaoHan ^a   Han, Yunfeng ^a,b   Sun, Kai ^e   Wang, Yibo ^e   Xin, Ying ^a   Bai, Yongyi ^a   Li, Weiju ^e   Yang, Tao ^e   Song, Xiaodong ^e   Wang, Hu ^e   Fu, Chunyan ^e   Chen, Jingzhou ^e   Shi, Yi ^e   Zhou, XianLiang ^a   Wu, Haiying ^a   Hui, Rutai ^a,c,d  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Division of Hypertension

^d FUWAI HOSPITAL   (China)

^e NONE

Author keywords

Antihypertensive drugs; Hypertension; Men; Women

Indexed keywords

ATENOLOL; CAPTOPRIL; HYDROCHLOROTHIAZIDE; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; EDEMA; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SUSTAINED DRUG RELEASE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATENOLOL; BLOOD PRESSURE; CAPTOPRIL; CHINA; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 57449113204     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L036     Document Type: Article

References (35)

1. Giardina EG. Heart disease in women. Int J Fertil Womens Med 2000;45:350-7.
2. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26 year follow-up of the Framingham population. Am Heart J 1986;111:383-90.
3. Yong LC, Kuller LH, Rutan G, Bunker C. Longitudinal study of blood pressure: changes and determinants from adolescence to middle age. The Dormont High School follow-up study, 1957-1963 to 1989-1990. Am J Epidemiol 1993;138:973-83.
4. Stamler J, Stamler R, Riedlinger Wf, Algera G, Roberts RH. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA 1976;235: 2299-306.
5. Burt VL, Whelton P, Rocella EJ, et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey. Hypertension 1996;25:305-13.
6. Martins D, Nelson K, Pan D, Tareen N, Norris K. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med 2001;4:10-3.
7. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
8. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004;286:R233-49.
9. Khalil RA. Sex hormones as potential modulators of vascular function in hypertension. Hypertension 2005;46:249-54.
10. Dubey RK, Imthurn B, Zacharia LC, Jackson EK. Hormone replacement therapy and cardiovascular disease: what went wrong and where do we go from here? Hypertension 2004;44:789-95.
11. Narkiewicz K, Kjeldsen SE, Hedner T. Hypertension and cardiovascular disease in women: progress towards better understanding of gender-specific differences? Blood Press 2006;15:68-70.
12. Safar ME, Smulyan H. Hypertension in women. Am J Hypertens 2004;17:82-7.
13. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993;88(5 pt 1):2460-70.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
15. International Diabetes Federation. New IDF worldwide definition of the metabolic syndrome. Press conference, 1st International Congress on "Pre-diabetes" and the Metabolic Syndrome, Berlin, Germany, April 14, 2005. www.idf.org (accessed 2005 Oct 12)
16. Liu L, Zhang Y, Liu G, et al. The Felodipine Event Reduction (FEVER) study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005;23:2157-72.
17. Franconi F, Brunelleschi S, Steardo L, Cuomo V. Gender differences in drug responses. Pharmacol Res 2007;55:81-95.
18. Ou Y, Share L, Crofton JT, Iitake K, Brooks DP. Sex difference in the development of deoxycorticosterone-salt hypertension in the rat. Hypertension 1987;9:172-7.
19. Eastwood JA, Doering LV. Gender differences in coronary artery disease. J Cardiovasc Nurs 2005;20:340-51.
20. Smulyan H, Asmar RG, Rudnicki A, London GM, Sarar ME. Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Cardiol 2001;37:1374-80.
21. Palatini P, Julius S. Heart rate and cardiovascular risk. J Hypertens 1997;15:3-17.
22. Safar ME, Myer MG, Leenen F, Asmar R. Gender influence on the dose ranging of a low dose perindopril-indapamide combination in hypertension: effect on systolic and pulse pressure. J Hypertens 2002;20:1653-61.
23. Chae CU, Pfeiffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999;281:634-9.
24. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985;291:97-104.
25. Mehvar R, Brocks DR. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans. J Pharm Pharm Sci 2001;4:185-200.
26. Luzier AB, Killian A, Wilton JH, Wilson MF, Forrest A, Kazierad DJ. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers. Clin Pharmacol Ther 1999;66:594-601.
27. Klungel OH, de Boer A, Paes AH, Seidell JC, Bakker A. Sex differences in the pharmacological treatment of hypertension: a review of population-based studies. J Hypertens 1997;15:591-600.
28. Wing LM, Reid CM, Ryan P, et al. A comparison of outcomes with angiotensin-converting-enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003;348:583-92.
29. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998;38:1003-9.
30. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 2005;45:522-5.
31. Pechere-Bertschlitz A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004;17:994-1001.
32. Cross HR, Murphy E, Koch WJ, Steenbergen C. Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide. Cardiovasc Res 2002;53:662-71.
33. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000;356:1955-64.
34. Myers MG, Reeves RA. White coat effect in treated hypertensive patients: sex differences. J Hum Hypertens 1995;9:729-33.
35. Reynolds K, Gu D, Muntner P, et al. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens 2003;21:1273-81